Dx Focus: Becton Dickinson's GBS Assay Gets FDA OK
March 29, 2012
Dx Focus: Becton Dickinson's GBS Assay Gets FDA OK
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Dx Focus: Clinical and Regulatory PCR and Nucleic Acid Testing News
August 5, 2010 / PCR Insider - Dx Focus: BD Max Cdiff; Hologic Aptima HPV; Inostics BEAMing Tech; Veredus Labs VereFlu Test
April 11, 2013 / PCR Insider - BD Diagnostics Division Sees 5 Percent Growth in FY Q1, but MDx Not Yet a Major Driver
February 7, 2013 / PCR Insider - Becton Dickinson Looks to Serve Several Market Segments as it Builds Out Molecular Testing Pipeline
January 3, 2013 / PCR Insider - BD Diagnostics, Diagenode Launch BD Max Flu A/B Test in Europe
November 8, 2012 / PCR Insider